Abstract:Overdose of acetaminophen (APAP), the most widely used analgesic, results in acute liver failure. We have investigated the role of a post‐translational modification of proteins called O‐GlcNAcylation in pathogenesis of APAP‐induced liver injury, where a single β‐D‐N‐acetylglucosamine (O‐GlcNAc) moiety is added to proteins by an enzyme called O‐GlcNAc transferase (OGT) and removed by an enzyme called O‐GlcNAcase (OGA). Male C57BL/6J mice were treated with 300 mg/kg APAP followed by Thiamet‐G (TMG, 400 mg/kg) a specific inhibitor of OGA that induces O‐GlcNAcylation, 1.5 hr after APAP administration. Progression of liver injury was studied over a time course of 0 to 24 hr. TMG treatment resulted in significant increase in hepatic O‐GlcNAc. The mice treated with 400 mg/kg TMG exhibited significantly higher APAP‐induced liver injury as indicated by increase in serum transaminase levels and histopathological analysis, as well as a prolonged JNK activation. Treatment with TMG did not affect hepatic CYP2E1 levels, APAP protein adduct formation, APAP induced mitochondrial damage, hepatic glutathione (GSH), or depletion of GSH after APAP treatment. C57BL/6J mice were also treated with 50 mg/kg TMG every other day for 15 days followed by 300 mg/kg APAP and sacrificed at 24 hr. Mice treated with 50 mg/kg TMG showed a similar increase in APAP‐induced liver injury. Next we used hepatocyte specific OGT knockout mice (OGT KO), which have decreased O‐GlcNAcylation to study APAP toxicity. OGT KO and WT control mice were treated with 300 mg/kg and sacrificed on a timecourse from 0–24 hr. OGT KO mice showed dramatic decrease in liver injury as compared to WT mice. APAP protein adducts was significantly decreased in OGT KO mice when compared to WT control mice. There was no difference CYP2E1 activity showing that OGT KO did not alter cytochrome P450 levels and alter APAP metabolism. Hepatic GSH depletion was equal in OGT KO and WT mice but GSH was rapidly replenished by 6hr after APAP treatment in OGT KO mice, while WT mice did not fully replenish until 24hr post APAP. Taken together, these data indicate that induction in cellular O‐GlcNAcylation exacerbates and decrease in O‐GlcNAcylation protects from APAP induced liver injury. These studies have identified a novel mechanism of pathogenesis of acute liver injury induced by APAP and highlighted a novel therapeutic target for acute liver failure. Support or Funding Information R01DK098414

Efficacy of oltipraz in preventing acetaminophen-induced liver injury in mice

8-methoxypsoralen protects against acetaminophen-induced liver injury by antagonising Cyp2e1 in mice

Effects of C2-Ceramide and Oltipraz on Hepatocyte Nuclear Factor-1 and Glutathione S-Transferase A1 in Acetaminophen-Mediated Acute Mice Liver Injury.

3,4-Dihydroxyphenylacetic acid, a microbiota-derived metabolite of quercetin, attenuates acetaminophen (APAP)-induced liver injury through activation of Nrf-2

Bifidobacterium Longum R0175 Protects Mice Against APAP-induced Liver Injury by Modulating the Nrf2 Pathway.

Allyl Methyl Trisulfide Protected Against Acetaminophen (Paracetamol)-Induced Hepatotoxicity by Suppressing CYP2E1 and Activating Nrf2 in Mouse Liver.

Acetaminophen-induced hepatocyte injury: C2-ceramide and oltipraz intervention, hepatocyte nuclear factor 1 and glutathione S-transferase A1 changes.

Oltipraz ameliorates the progression of steatohepatitis in Nrf2-null mice fed a high-fat diet

Oltipraz attenuated cerebral ischemia-reperfusion injury through inhibiting the oxidative stress and ferroptosis in mice

Inhibiting Hepatocyte Uric Acid Synthesis and Reabsorption Ameliorates Acetaminophen-Induced Acute Liver Injury in Mice.

Oroxyloside Ameliorates Acetaminophen-Induced Hepatotoxicity by Inhibiting JNK Related Apoptosis and Necroptosis.

Hepatoprotective Effect of Polysaccharides Isolated from Dendrobium officinale against Acetaminophen-Induced Liver Injury in Mice via Regulation of the Nrf2-Keap1 Signaling Pathway

Disruption of peroxisome proliferator-activated receptor α in hepatocytes protects against acetaminophen-induced liver injury by activating the IL-6/STAT3 pathway

4-Hydroxyphenylacetic Acid Prevents Acute APAP-Induced Liver Injury by Increasing Phase II and Antioxidant Enzymes in Mice

Mitoquinone protects against acetaminophen-induced liver injury in an FSP1-dependent and GPX4-independent manner

Effect of trifluoperazine on toxicity, HIF-1α induction and hepatocyte regeneration in acetaminophen toxicity in mice

Apigenin Prevents Acetaminophen-Induced Liver Injury by Activating the SIRT1 Pathway

Inhibition of Mitochondrial Complex I by Rotenone Protects Against Acetaminophen-Induced Liver Injury.

Atractylenolide I Ameliorates Acetaminophen-Induced Acute Liver Injury via the TLR4/MAPKs/NF-κB Signaling Pathways

Role of Hepatic O‐GlcNAcylation on Acetaminophen‐Induced Liver Injury

Protective effects of oleanolic acid on acetaminophen-induced hepatotoxicity in mice.